Accrued Expenses |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Payables and Accruals [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Accrued Expenses | Note 7 – Accrued Expenses
Accrued expenses at March 31, 2026, and December 31, 2025, consisted of the following:
The Company provides postretirement benefits pursuant to IRS code section 401(k) for employees meeting specified criteria. The Company matches 100% of the employees’ contributions that are not in excess of 2% of the employee’s contributions. These matching contributions are fully vested and paid pursuant to the employees’ bi-weekly or semi-monthly pay periods. The Company does not prefund these benefits and has the right to modify or terminate certain of these benefits in the future. For the three months ended March 31, 2026, the Company incurred $7,322 of IRA contribution expenses pursuant to the Company’s matching contributions, including $0, as accrued at March 31, 2026. For the three months ended March 31, 2025, the Company incurred $20,393 of IRA contribution expenses pursuant to the Company’s matching contributions.
|
|||||||||||||||||||||||||||||||||||||||||||||